Advisory: Dated alert on Anebulo Pharmaceuticals' voluntary delisting from Nasdaq withdrawn
An alert on Anebulo Pharmaceuticals' ANEB.O voluntary delisting from Nasdaq has been withdrawn as it was dated. The company last week announced the delisting. For the correct set of alerts, click (Full story). STORY_NUMBER: nFWN3Z81NP STORY_DATE: 12th February 2026 STORY_TIME: 09:17:21 PM GMT ((Bangalore.newsroom@thomsonreuters.com))
Recent news on Anebulo Pharmaceuticals
See all newsAdvisory: Dated alert on Anebulo Pharmaceuticals' voluntary delisting from Nasdaq withdrawn
Anebulo Pharmaceuticals Q2 net loss narrows
Brief: Anebulo Pharmaceuticals Announces Intention To Voluntarily Delist From Nasdaq And Deregister With SEC
Anebulo Pharmaceuticals posts Q1 net loss
Brief: Anebulo Pharmaceuticals Reports Fourth Quarter And Fiscal Year 2025 Financial Results